MRN–CtIP, EXO1, and DNA2–WRN/BLM act bidirectionally to process DNA gaps in PARPi-treated cells without strand cleavage
Genes & Development · 01.05.2025 · 39 (9-10) · 582-602
DOI: 10.1101/gad.352421.124 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes & Development, online erschienen am 24.03.2025. Verfasst von Isabelle M Seppa und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Oncology, Department of Medicine, Washington University in St. Louis, St. Louis, Missouri 63110, USA. Hauptthemen laut MEDLINE: Exodeoxyribonucleases, Poly(ADP-ribose) Polymerase Inhibitors, DNA Repair Enzymes, DNA Helicases. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute, Alvin J. Siteman Cancer Center Siteman Investment Program.
Abstract (Originalsprache)
Single-stranded DNA (ssDNA) gaps impact genome stability and PARP inhibitor (PARPi) sensitivity, especially in BRCA1/2-deficient tumors. Using single-molecule DNA fiber analysis, electron microscopy, and biochemical methods, we found that MRN, CtIP, EXO1, and DNA2–WRN/BLM resect ssDNA gaps through a mechanism different from their actions at DNA ends. MRN resects ssDNA gaps in the 3′-to-5′ direction using its pCtIP-stimulated exonuclease activity. Unlike at DNA ends, MRN does not use its endonucleolytic activity to cleave the 5′-terminated strand flanking the gap or the ssDNA. EXO1 and DNA2–WRN/BLM specifically resect the 5′ end of the gap independent of MRN–CtIP. This resection process alters ssDNA gap repair kinetics in BRCA1-proficient and -deficient cells. In BRCA1-deficient cells treated with PARPis, excessive resection results in larger ssDNA gaps, hindering their repair and leading to DNA breaks in subsequent cell cycle stages due to ssDNA gaps colliding with DNA replication forks. These findings broaden our understanding of the role of human nucleases in DNA metabolism and have significant implications for defining the mechanisms driving PARPi sensitivity in BRCA-deficient tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Oncology, Department of Medicine, Washington University in St. Louis, St. Louis, Missouri 63110, USA.
- Institute for Research in Biomedicine (IRB), Università della Svizzera italiana, CH 6500 Bellinzona, Switzerland.
- Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
- Division of Oncology, Department of Medicine, Washington University in St. Louis, St. Louis, Missouri 63110, USA; avindigni@wustl.edu.
ORCID-Profile: Alessandro Vindigni
Förderung
- NCI NIH HHS
- National Cancer Institute
- Alvin J. Siteman Cancer Center Siteman Investment Program
- Barnard Foundation
- Swiss National Science Foundation
- European Research Council
- Novartis Foundation
Zitieren
APA
Seppa, I. M., Ceppi, I., Tennakoon, M., Reginato, G., Jackson, J., Rouault, C. D., Agashe, S., Sviderskiy, V. O., Limbu, M., Lantelme, E., Meroni, A., Braunshier, S., Borrello, D., Verma, P., Cejka, P., & Vindigni, A. (2025). MRN–CtIP, EXO1, and DNA2–WRN/BLM act bidirectionally to process DNA gaps in PARPi-treated cells without strand cleavage. Genes & Development, 39(9-10), 582-602. https://doi.org/10.1101/gad.352421.124
Vancouver
Seppa IM, Ceppi I, Tennakoon M, Reginato G, Jackson J, Rouault CD, et al. MRN–CtIP, EXO1, and DNA2–WRN/BLM act bidirectionally to process DNA gaps in PARPi-treated cells without strand cleavage. Genes & Development. 2025;39(9-10):582-602. doi:10.1101/gad.352421.124
BibTeX
@article{Seppa2025,
author = {Seppa, Isabelle M and Ceppi, Ilaria and Tennakoon, Mithila and Reginato, Giordano and Jackson, Jessica and Rouault, Celia D and Agashe, Sumedha and Sviderskiy, Vladislav O and Limbu, Mangsi and Lantelme, Erica and Meroni, Alice and Braunshier, Stefan and Borrello, Damiano and Verma, Priyanka and Cejka, Petr and Vindigni, Alessandro},
title = {MRN–CtIP, EXO1, and DNA2–WRN/BLM act bidirectionally to process DNA gaps in PARPi-treated cells without strand cleavage},
journal = {Genes & Development},
year = {2025},
volume = {39},
number = {9-10},
pages = {582--602},
doi = {10.1101/gad.352421.124}
}
EUVIMED